Stemsation International, Inc. (STSN)

0.0174 +0.0075 (+76.26%) As of 02:24PM EDT. Market open.

Stemsation International, Inc.

7777 Glades Road
Suite 203
Boca Raton, FL 33434
United States
561-245-7454
https://www.stemsation.global

Sector(s): Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Full-time employees: 

Key executives

Name	Title	Pay	Exercised	Year born
Mr. Ray C. Carter Jr.	Founder, CEO & President	N/A	N/A	N/A
Dr. Mira Gadzala Ph.D.	Chief Science Officer	N/A	N/A	N/A
Ms. Svetlana Nedkovska	Managing Director of Europe	N/A	N/A	N/A
Mr. Nicholas B. Panza	Secretary	N/A	N/A	N/A

Amounts are as of , and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

StemSation International, Inc. develops, manufactures, and distributes natural wellness products that support the stem cell and endocannabinoid systems in the human body. It offers StemRCM, a dietary supplement that supports stem cells ability to repair, renew, and restore tissues and organ function through healthy stem cell release, circulation, and migration. The company sells its products through independent wellness advocates directly to consumers. StemSation International, Inc. is headquartered in Boca Raton, Florida.

Corporate governance

Stemsation International, Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.